Use of Pembrolizumab Expanded to 13th Type of Cancer in Five Years
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
Author:
Karen Honey, PhD
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...
Therapeutics that target two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6 have revolutionized treatment for breast cancer, Richard...
Over the course of AACR Annual Meeting 2019, there were 213 presentations on incredibly exciting clinical trials. This is...
“Do you want to have fun?” Richard Pazdur, MD, director of the U.S. Food and Drug Administration (FDA) Oncology...
Cancer prevention refers to measures that people can take to reduce their risk of developing cancer. These measures can...
Non-Hispanic black men in the United States are much more likely to develop prostate cancer and to die from...
Last Friday, March 8, 2019, marked another milestone in immuno-oncology: The U.S. Food and Drug Administration (FDA) announced the...